179 related articles for article (PubMed ID: 12695174)
1. Methotrexate is the leading DMARD in Finland.
Klaukka T; Kaarela K
Ann Rheum Dis; 2003 May; 62(5):494; author reply 494-5. PubMed ID: 12695174
[No Abstract] [Full Text] [Related]
2. Combination DMARD therapy with hydroxychloroquine, sulfasalazine, and methotrexate.
O'Dell JR
Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S53-8. PubMed ID: 10589358
[TBL] [Abstract][Full Text] [Related]
3. Changing sulphasalazine to methotrexate does not improve the 2-year outcomes of the initial single DMARD treatment in early rheumatoid arthritis: subanalysis of the FIN-RACo trial.
Rantalaiho VM; Kautiainen H; Korpela M; Hannonen PJ; Leirisalo-Repo M; Möttönen T;
Ann Rheum Dis; 2013 May; 72(5):786-8. PubMed ID: 23349132
[No Abstract] [Full Text] [Related]
4. The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritis.
Furst DE
Clin Exp Rheumatol; 1999; 17(1):39-40. PubMed ID: 10084027
[No Abstract] [Full Text] [Related]
5. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
O'Dell JR; Haire C; Erikson N; Drymalski W; Palmer W; Maloley P; Klassen LW; Wees S; Moore GF
J Rheumatol Suppl; 1996 Mar; 44():72-4. PubMed ID: 8833058
[TBL] [Abstract][Full Text] [Related]
6. Treatment of rheumatoid arthritis.
Stohl W; Arkfeld DG
N Engl J Med; 1996 Sep; 335(11):821-2; author reply 822-3. PubMed ID: 8778593
[No Abstract] [Full Text] [Related]
7. Making rational treatment decisions in rheumatoid arthritis when methotrexate fails.
Bathon JM; McMahon DJ
N Engl J Med; 2013 Jul; 369(4):384-5. PubMed ID: 23755970
[No Abstract] [Full Text] [Related]
8. Treatment of rheumatoid arthritis.
Zurier RB; DeMarco DM; Liu NY
N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778595
[No Abstract] [Full Text] [Related]
9. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
[TBL] [Abstract][Full Text] [Related]
10. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.
O'Dell JR; Haire CE; Erikson N; Drymalski W; Palmer W; Eckhoff PJ; Garwood V; Maloley P; Klassen LW; Wees S; Klein H; Moore GF
N Engl J Med; 1996 May; 334(20):1287-91. PubMed ID: 8609945
[TBL] [Abstract][Full Text] [Related]
11. Improving patient-centred care for rheumatoid arthritis.
Bansback N; Shojania K; Lacaille D
CMAJ; 2016 Oct; 188(14):999-1000. PubMed ID: 27354676
[No Abstract] [Full Text] [Related]
12. A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine.
Wojciechowski J; Wiese MD; Proudman SM; Foster DJ; Upton RN
Br J Clin Pharmacol; 2015 May; 79(5):777-88. PubMed ID: 25394211
[TBL] [Abstract][Full Text] [Related]
13. [The goal for the treatment of rheumatoid arthritis should be remission].
Möttönen T; Mäkinen H; Puolakka K
Duodecim; 2010; 126(12):1457-64. PubMed ID: 20617749
[TBL] [Abstract][Full Text] [Related]
14. Triple therapy with non-biologic DMARDs for rheumatoid arthritis or biologic therapy. Is it the same?
Abud-Mendoza C; Martínez-Martínez MU
Reumatol Clin; 2014; 10(5):345-6. PubMed ID: 24681058
[No Abstract] [Full Text] [Related]
15. Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.
Rannio T; Asikainen J; Hannonen P; Yli-Kerttula T; Ekman P; Pirilä L; Kuusalo L; Mali M; Puurtinen-Vilkki M; Kortelainen S; Paltta J; Taimen K; Kauppi M; Laiho K; Nyrhinen S; Mäkinen H; Isomäki P; Uotila T; Aaltonen K; Kautiainen H; Sokka T
Scand J Rheumatol; 2017 Nov; 46(6):425-431. PubMed ID: 28367663
[TBL] [Abstract][Full Text] [Related]
16. Conventional triple therapy as good as etanercept for uncontrolled rheumatoid arthritis.
BMJ; 2013 Jun; 346():f3846. PubMed ID: 23778977
[No Abstract] [Full Text] [Related]
17. [Update on Current Care Guidelines. Rheumatoid Arthritis (RA)].
Duodecim; 2015; 131(15):1409-10. PubMed ID: 26433976
[TBL] [Abstract][Full Text] [Related]
18. Disease-modifying antirheumatic drugs.
Brasington R
J Hand Surg Am; 2009 Feb; 34(2):347-8. PubMed ID: 19181237
[No Abstract] [Full Text] [Related]
19. Therapies for active rheumatoid arthritis after methotrexate failure.
O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E;
N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969
[TBL] [Abstract][Full Text] [Related]
20. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
Mary J; De Bandt M; Lukas C; Morel J; Combe B
J Rheumatol; 2017 Jun; 44(6):773-779. PubMed ID: 28412710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]